See You at the Spotlight
Closing in on Undiagnosable Tumors – The Case for 3D Genome Profiling of All Cancers
Sunday, April 10 | 3:30 – 4:30 pm
Spotlight Theater B
Arima Genomics provides 3D genomic technologies that enable researchers to uncover novel disease mechanisms and identify new therapeutic targets. Join us to learn how spatial and temporal changes in DNA organization impact tumorigenesis.
This session will feature Matija Snuderl, MD, of NYU Langone Health and School of Medicine, who will share the results of a collaboration between Arima Genomics and NYU to identify the genetic drivers of previously undiagnosable tumors. Anthony Schmitt, PhD, SVP of Science at Arima Genomics, will host this spotlight and share exciting new developments towards advancing discoveries in cancer biology.
Register Now
Meet the Speakers
Matija Snuderl, MD
NYU Langone Health and School of MedicineDr. Matija Snuderl is a neuropathologist at NYU Langone whose clinical research focuses on identifying novel biomarkers for diagnosis and therapy. Dr. Snuderl's laboratory at NYU Langone studies cancer genetics and epigenetics and examines the molecular differences between tumors at the cellular level.
Anthony Schmitt, PhD
Senior Vice President, ScienceAnthony Schmitt has led the development of the core Arima Hi-C chemistry and technology platform since Arima’s inception, contributed to core inventions and technology development grants, and continues to lead the R&D programs for targeted chromosome conformation capture techniques.
See You at the Poster Sessions
Sensitive and Unbiased Detection of Clinically Actionable Gene Fusions from FFPE Tumor Biopsies Using the Arima-HiC Platform
Sunday, April 10 | 1:30 – 5:00 pm
Poster Section: 4 | Board Number: 21 | Abstract ID: 84
Identification of Clinically Relevant Gene Fusions in Archived Pediatric Solid and Liquid Tumor Samples using Arima-HiC Sequencing
Tuesday, April 12 | 9:00 am – 12:30 pm
Poster Section: 13 | Board Number: 13 | Abstract ID: 2503
Cancer Research Grant
Apply by May 4, 2022, to win a free Arima kit to gain unparalleled access to the sequence, structure, and regulatory landscape of cancer genomes.
Learn More and Apply